Inspire Medical Systems Price to Free Cash Flow Ratio 2017-2024 | INSP
Historical price to free cash flow ratio values for Inspire Medical Systems (INSP) since 2017.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Inspire Medical Systems Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-16 | 152.67 | 51.17 | |
| 2024-12-31 | 185.38 | $2.98 | 62.14 |
| 2024-09-30 | 211.05 | $1.26 | 167.47 |
| 2024-06-30 | 133.83 | $-0.30 | 0.00 |
| 2024-03-31 | 214.79 | $0.11 | 1879.18 |
| 2023-12-31 | 203.43 | $0.03 | 5828.94 |
| 2023-09-30 | 198.44 | $0.30 | 663.68 |
| 2023-06-30 | 324.64 | $0.70 | 467.11 |
| 2023-03-31 | 234.07 | $0.42 | 556.91 |
| 2022-12-31 | 251.88 | $0.09 | 2859.02 |
| 2022-09-30 | 177.37 | $-0.48 | 0.00 |
| 2022-06-30 | 182.67 | $-0.82 | 0.00 |
| 2022-03-31 | 256.69 | $-0.98 | 0.00 |
| 2021-12-31 | 230.06 | $-0.91 | 0.00 |
| 2021-09-30 | 232.88 | $-1.15 | 0.00 |
| 2021-06-30 | 193.26 | $-1.44 | 0.00 |
| 2021-03-31 | 206.99 | $-1.94 | 0.00 |
| 2020-12-31 | 188.09 | $-2.13 | 0.00 |
| 2020-09-30 | 129.05 | $-2.17 | 0.00 |
| 2020-06-30 | 87.02 | $-1.99 | 0.00 |
| 2020-03-31 | 60.28 | $-1.64 | 0.00 |
| 2019-12-31 | 74.21 | $-1.49 | 0.00 |
| 2019-09-30 | 61.02 | $-1.76 | 0.00 |
| 2019-06-30 | 60.65 | $-1.42 | 0.00 |
| 2019-03-31 | 56.78 | $-1.78 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.415B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.307B | 54.29 |
| Hims & Hers Health (HIMS) | United States | $13.112B | 136.23 |
| Tempus AI (TEM) | United States | $10.781B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.503B | 0.00 |
| Privia Health (PRVA) | United States | $3.036B | 207.50 |
| Enovis (ENOV) | United States | $2.041B | 11.38 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.529B | 0.00 |
| Omnicell (OMCL) | United States | $1.315B | 23.21 |
| Azenta (AZTA) | United States | $1.223B | 56.83 |
| 10x Genomics (TXG) | United States | $1.125B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Talkspace (TALK) | United States | $0.500B | 149.50 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.368B | 816.67 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.147B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |